Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal

View ORCID ProfilePaula Meireles, View ORCID ProfileJoana Amaro, View ORCID ProfileJoana Pinto Costa, View ORCID ProfileMariana Mendes Lopes, View ORCID ProfileTatiana Varandas, View ORCID ProfilePedro Norton, View ORCID ProfileJoão Tiago Guimarães, View ORCID ProfileMilton Severo, View ORCID ProfileHenrique Barros
doi: https://doi.org/10.1101/2021.02.28.21252628
Paula Meireles
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paula Meireles
  • For correspondence: paula.meireles@ispup.up.pt
Joana Amaro
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
4Faculdade de Medicina, Universidade do Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joana Amaro
Joana Pinto Costa
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joana Pinto Costa
Mariana Mendes Lopes
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mariana Mendes Lopes
Tatiana Varandas
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tatiana Varandas
Pedro Norton
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
2Serviço de Saúde Ocupacional, Centro Hospitalar Universitário de São João, Porto, Portugal
4Faculdade de Medicina, Universidade do Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pedro Norton
João Tiago Guimarães
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
3Serviço de Patologia Clínica, Centro Hospitalar Universitário de São João, Porto, Portugal
4Faculdade de Medicina, Universidade do Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for João Tiago Guimarães
Milton Severo
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Milton Severo
Henrique Barros
1EPIUnit–Instituto de Saúde Pública, Universidade do Porto, Rua das Taipas, nº 135, 4050-600 Porto, Portugal
4Faculdade de Medicina, Universidade do Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Henrique Barros
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To assess the prevalence of SARS-CoV-2 specific immunoglobulin (Ig) M and IgG antibodies among workers of the three public higher education institutions of Porto, Portugal, up to July 2020.

Methods A rapid point of care test for specific IgM and IgG antibodies of SARS-CoV-2 was offered to all workers. Testing was performed to and a questionnaire was completed by 4592 workers on a voluntary basis. We computed the apparent IgM, IgG, and combined IgM or IgG prevalence, along with the true prevalence and 95% credible intervals (95% CI) using Bayesian inference.

Results We found an apparent prevalence of 3.1% for IgM, 1.0% for IgG, and 3.9% for either antibody class. The estimated true prevalence was 2.0% (95% CI 0.1-4.3) for IgM, 0.6% (95% CI 0.0-1.3) for IgG and 2.5% (95% CI 0.1-5.3) for IgM or IgG. A SARS-CoV-2 molecular diagnosis was reported by 21 (0.5%) workers, and of these, 90.5% had a reactive IgG result. Seroprevalence was higher among those reporting known contacts with confirmed cases, having been quarantined, having a previous molecular negative test, or having had symptoms.

Conclusions The seroprevalence among workers from the three public higher education institutions of Porto after the first wave of the SARS-CoV-2 infection was relatively low. However, the estimated true seroprevalence was approximately five times higher than the reported SARS-CoV-2 infection based on a molecular test result.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

National funds of Fundacao para a Ciencia e Tecnologia (FCT), under the scope of the project UIDB/04750/2020 - Research Unit of Epidemiology-Institute of Public Health of the University of Porto (EPIUnit). Joana Amaro was the recipient of PhD grant (PD/BD/128009/2016) co-funded by the national funds of FCT and the Programa Operacional Capital Humano/Fundo Social Europeu (POCH/FSE). Joana Costa was the recipient of PhD grant 2020.08562.BD co-funded by the national funds of FCT and the Fundo Social Europeu (FSE).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study protocol was approved by the ethics committee of the Institute of Public Health of the University of Porto (ID 20154).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data may be obtained from a third party upon reasonable request sent to saude.ocupacional@ispup.up.pt.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 02, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal
Paula Meireles, Joana Amaro, Joana Pinto Costa, Mariana Mendes Lopes, Tatiana Varandas, Pedro Norton, João Tiago Guimarães, Milton Severo, Henrique Barros
medRxiv 2021.02.28.21252628; doi: https://doi.org/10.1101/2021.02.28.21252628
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Prevalence of SARS-CoV-2 antibodies among workers of the public higher education institutions of Porto, Portugal
Paula Meireles, Joana Amaro, Joana Pinto Costa, Mariana Mendes Lopes, Tatiana Varandas, Pedro Norton, João Tiago Guimarães, Milton Severo, Henrique Barros
medRxiv 2021.02.28.21252628; doi: https://doi.org/10.1101/2021.02.28.21252628

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (525)
  • Anesthesia (125)
  • Cardiovascular Medicine (1437)
  • Dentistry and Oral Medicine (221)
  • Dermatology (158)
  • Emergency Medicine (293)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (590)
  • Epidemiology (10339)
  • Forensic Medicine (6)
  • Gastroenterology (534)
  • Genetic and Genomic Medicine (2658)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1745)
  • Health Policy (791)
  • Health Systems and Quality Improvement (682)
  • Hematology (270)
  • HIV/AIDS (571)
  • Infectious Diseases (except HIV/AIDS) (12122)
  • Intensive Care and Critical Care Medicine (650)
  • Medical Education (276)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2486)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (498)
  • Occupational and Environmental Health (569)
  • Oncology (1338)
  • Ophthalmology (404)
  • Orthopedics (153)
  • Otolaryngology (239)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (345)
  • Pediatrics (787)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (297)
  • Psychiatry and Clinical Psychology (2424)
  • Public and Global Health (5035)
  • Radiology and Imaging (903)
  • Rehabilitation Medicine and Physical Therapy (536)
  • Respiratory Medicine (688)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (301)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)